Jump to content
Powered by

Dossiers

Here you can find dossiers on topics related to the healthcare industry. New articles about state-of-the-art knowledge will always be posted in the overview articles section.

  • Dossier - 23/01/2012

    Robots that move like ants, brain electrodes that alleviate symptoms of Parkinson’s, arm prostheses that can be controlled with pure thought power – over the last few years enormous progress has been made in the neurosciences and there has been an increasing shift from pure basic to applied research. There is a great deal of creativity in applied research in Baden-Württemberg. Nevertheless, basic research in the southwest of Germany has never…

  • Dossier - 12/12/2011

    Biomarkers are playing an increasing role in drug discovery and development. They can be used as molecular indicators for diseases and disease risks as well as for monitoring the effectiveness of therapy. Highly specific molecular biomarkers are being identified using state-of-the-art technologies from the fields of genomics, proteomics and metabolomics.

  • Dossier - 14/11/2011

    The EU Nutrition and Health Claims Regulation applies to all nutrition and health claims made in commercial communications, including the advertising and labelling of food and promotional campaigns. While the information related to nutrition is now clear, the list of permitted health claims is still under development.

  • Dossier - 10/10/2011

    Biotechnology companies have always had international ties: they employ cutting-edge technologies and market the discoveries and developments of researchers around the world. Rapid innovation cycles and rapid technological developments force companies to undertake costly R&D as well as market their products and/or services across national borders.

  • Dossier - 05/10/2011

    As blockbuster biopharmaceuticals go off patent, biosimilars are increasingly competing with them for a market share. However, the production of biosimilars is rather complex and costly. The approval of biosimilars is also subject to many hurdles. Their introduction to the very expensive biopharmaceuticals market is often associated with marginal price reductions.

  • Dossier - 19/09/2011

    Social network services are springing up like mushrooms; everybody seems to be talking about ‘Web 2.0’ or ‘Podcast’. The life sciences are also starting to use the new communication media for their purposes. Social network services are online platforms with a representation of each individual user who links up with a number of different social networks composed of other users. Terms like Web 2.0 and Podcast are commonly used and the World Wide…

  • Dossier - 22/08/2011

    Organisms can experience stress from exposure to bacteria and pathogenic fungi; in fact, stress can arise from exposure to any type of environmental influence. As they have evolved, biological cells have developed numerous molecular mechanisms that enable them to survive even in inhospitable conditions. What kind of effects do abiotic stress factors have on plants and human beings? How do cells protect themselves? Are researchers able to increase…

  • Dossier - 25/07/2011

    The history of cell culture technology is closely connected with cell biology and the discoveries made in the field of cell biology. Ever since the study of science became a professional activity, researchers have been trying to keep cells and tissues alive outside organisms for purposes of investigation.

  • Dossier - 04/07/2011

    People’s life expectancy is increasing due to constantly improving medical treatment. One result of this is the greater wear of joints, which then need to be replaced with implants. Increased life expectancy means that the implants remain in the body for much longer and therefore need to be longer lasting. The revision rate of implant materials used in clinical practice is still as much as 10 per cent, particularly in the case of hip and knee…

  • Dossier - 30/05/2011

    Technology transfer that efficiently exploits the intellectual property created by publicly funded research is necessary in order to turn scientific discoveries into successful innovations that improve people’s quality of life and boost the economy. The efforts made to rapidly transfer research results from the laboratory into clinical application for the benefit of patients leads to new strategic partnerships and structures in the field of…

  • Dossier - 02/05/2011

    Knowledge about the molecular organisation of structural and functional biological properties has led to the establishment of a new field of research molecular bionics. Everything that can be learnt from the macromolecular observation of interesting natural phenomena is complemented in this field by observations on the smallest i.e. molecular level. Processes and materials that have been optimised in the course of evolution are thus able to…

  • Dossier - 28/02/2011

    According to the Federal Health Monitoring Information System a persons life expectancy is reduced by around one per cent due to allergies and their effects. Knowledge about the molecular mechanisms that lead to disorders in the interplay of the immune system and the environment is a prerequisite for developing new therapies for the causal treatment of allergies.

Website address: https://www.gesundheitsindustrie-bw.de/en/article/dossier